Let's Get Started

Biotech

Infinity Pharmaceuticals INFI Stock Price has consolidated and could be ready for a run? URGENT URGENT

Mar 31, 2022

Infinity Pharmaceuticals INFI stock price is finally showing some life as it possibly reverses trend. SMCE is up 7% in the last 5 days and I will be evaluating many factors to determine just how hot the stock is.

The official heat level for INFI is, a 🔥🔥 2 out of 5.

Continue reading to see why I think it is just a 2 out of 5. There is some shocking takeaways from this article that you must read if you are interested in SMCE.

If you are interested in finding out more about me, famed stock picker, Alexander Goldman or if you’re interested in my HOT grading system, sign up today, it’s FREE!

👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥🔥 HOT stocks and trending stocks!👇 In fact, I will send you personally a 🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter.


[thrive_leads id=’14274′]

Before I go over this exciting trending stock, I wanted to introduce myself. Hello 🙋‍♂️ My name is Alexander Goldman. I have been trading, at a very high level, breakout stocks and trending stocks for 20 years now. I’m accredited for establishing the coveted HOT grading system for trending stocks.

I found my home at Small Cap exclusive 4 years ago. Now, I’m helping traders find breakout stocks. Not to sound egotistical but I’m very good at finding small cap stocks that are winners.

What do I mean by big winners?

Stocks that move more than 100% in a month! INFI Stock Price could?

Does that always happen, NO! But, I’m very consistent! Take a look at this article I wrote below, where I called 5 stocks, 3 losers and 2 winners and they all did what I thought!

The article is HERE and I shine a spotlight on these breakout stocks and also those losers!

Now, let’s go over some of the basic information on this stock before we get in the technical analysis and how I came up with HOT grade.

Infinity Pharmaceuticals Company Information

Company Name: Infinity Pharmaceuticals Inc.

Ticker: INFI

Exchange: NASDAQ

Website: https://www.infi.com/

Breakout Stock Infinity Pharmaceuticals Company Summary:

Infinity Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. It focuses on drug development. The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA.

INFI stock price is due to News?

March 29th

Announced its full year 2021 financial results and provided corporate highlights.

“Based on the strength and breadth of eganelisib’s activity across mTNBC and mUC as well as ovarian cancer, SCCHN, and melanoma, we raised $92 million in early 2021 to advance eganelisib to its first registration-enabling study by the end of this year.

INFI

INFI Stock Price HOT Stock Grade:

The official heat level for INFI is, a 🔥🔥 2 out of 5 . Continue reading to see why I think it is just a 2 out of 5. Here are my takeaways on INFI and why it is just a 2 out of 5.

The volume, which is basically demand of a stock is significantly higher than thee norm at a 77% ratio. Hence, that is a strong indicator of interest which is one variable of PPS.

The news, there is significant news in the way of the 92 million dollars. This news is probably driving the volume spike.

The chart, it is neutral as of the 1 day and slightly bullish on the 5 day.

The fundamentals, there is no exciting financial filings associated with this stock.

Marketing efforts, I have not found marketing efforts around the investor awareness of this company.

In conclusion, I am in a hold pattern with INFI and will await a break of $1.20, a resistance point, to confirm a true reversal.

To receive my 🔥🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter, sign up today.

👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥🔥 HOT stocks and trending stocks!👇


[thrive_leads id=’14274′]

read more

WHSI stock price, is it time to buy or sell? Exclusive analysis!

Mar 17, 2022

Wearable Health Solutions Inc. WHSI stock price and chart looks great, is it time to sell or rebuy? Famed stock picker, Alexander Goldman has his analysis, take a look below.

Before we do, remember to stop what you are doing and 👇 Sign up for our newsletter to get the latest breakout stocks and trending stocks!


[thrive_leads id=’14274′]

Before we get started, I wanted to introduce myself to you. Hi 🙋‍♂️ I’m Alexander Goldman and I have been successfully trading breakout stocks and trending stocks for two decades now.

I’m now helping traders find breakout stocks. My claim to fame is the expert at finding trending stocks.

What do I mean by big winners?

Stocks that move more than 100% in a month! WHSI Stock Price could?

Does that always happen, NO! But, I’m very good! Take a look at this article I wrote, where I called 5 stocks, 3 losers and 2 winners and they all did what I thought!

The article is HERE where I shine a spotlight on trending stocks and breakout stocks!

If you want stocks delivered to your inbox, no hassle, no research with this massive community of traders, sign up below. Now, let’s go over some of the basic information on this stock before we get in the technical analysis.

Wearable Health Solutions Inc. Company Information

Company Name: Wearable Health Solutions Inc.

Ticker: WHSI

Exchange: OTC

Website: https://www.wearablehealthsolutions.com/

Wearable Health Solutions Inc. Company Summary:

Wearable Health Solutions, Inc. engages in the manufacturing of medical alarm devices. Its products include MediPendant which allows the user to speak and listen to the operator directly through the pendant.

Also iHelp+3GTM which has the ability to detect if the wearer of the unit falls such as in the shower, have geo-fencing and tracking ability, will operate on the third generation networks, and be telehealth enabled via blue tooth low energy. The company was founded by Howard Teicher on June 4, 2008 and is headquartered in Ontario, Canada.

WHIS stock price is due to News?

January 21, 2021

Announced on June 2, 2021 that it had entered into an agreement with Worldwide Business with kathy ireland®, to create impactful video pieces in a credible 3rd party format for use in promos and social media, today announced that the production is scheduled to start on February 8, 2022.

WHIS 5 Day Chart

WHSI stock price

WUC Stock Price Technical Analysis:

The chart looks like it consolidated. I like the stock if it can beat $.27 soon, otherwise it will fall bearish.

Once again my name is Alex and I’m so glad you took the time to read this far. I would love to have you be apart of our growing family of traders.

I always like giving tid bits of knowledge that I have learned from my mentors, so here goes. As a reminder to all of the traders out there to leave your emotions at the door and never, ever, try to catch a falling safe. Simply let it crash to the ground and then, walk over and pick up the money. That is a reference to bounce plays LOL.

I strive to find breakout stock alerts and deliver them before the market finds out. I’m the original OG trend setter of trending stocks! If you want stocks delivered to your inbox, no hassle, no research with this massive community of traders, sign up below.

I sure hope you enjoyed this article, if you would like to receive more exclusive content from me sign up for our newsletter below 👇


[thrive_leads id=’14274′]

read more

CTI BioPharma Corp. CTIC stock price, is it time to sell or rebuy? Exclusive analysis!

Mar 10, 2022

CTI BioPharma Corp. CTIC stock price is at an all-time high, is it time to sell or rebuy? Famed stock picker, Alexander Goldman has his analysis, take a look below.

Before we do, remember to stop what you are doing and 👇 Sign up for our newsletter to get the latest breakout stocks and trending stocks!


[thrive_leads id=’14274′]

Before we get started, I wanted to introduce myself to you. Hi 🙋‍♂️ I’m Alexander Goldman and I have been successfully trading breakout stocks and trending stocks for two decades now.

I’m now helping traders find breakout stocks. My claim to fame is the expert at finding trending stocks.

What do I mean by big winners?

Stocks that move more than 100% in a month! CTIC Stock Price could?

Does that always happen, NO! But, I’m very good! Take a look at this article I wrote, where I called 5 stocks, 3 losers and 2 winners and they all did what I thought!

The article is HERE where I shine a spotlight on trending stocks and breakout stocks!

If you want stocks delivered to your inbox, no hassle, no research with this massive community of traders, sign up below. Now, let’s go over some of the basic information on this stock before we get in the technical analysis.

CTI BioPharma Corp. Company Information

Company Name: CTI BioPharma Corp.

Ticker: CTIC

Exchange: NASDAQ

Website: https://www.ctibiopharma.com/

CTI BioPharma Corp. Company Summary:

CTI BioPharma Corp. is a biopharmaceutical company, which focuses on the development, acquisition and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.

CTIC stock price is due to News?

March 2, 2022

Announced that management will provide a corporate overview at the Cowen Annual Healthcare Conference at 1:30 p.m. ET. The conference will be held in a virtual meeting format.

CTIC 5 Day Chart

CTIC stock price

CTIC Stock Price Technical Analysis:

I love the chart, it is bullish and very steady in it’s gains. It is up 163% in three months and that is a little frightening, so I would wait for a pullback then snatch it up. We will keep an eye on this one!

Once again my name is Alex and I’m so glad you took the time to read this far. I would love to have you be apart of our growing family of traders.

I always like giving tid bits of knowledge that I have learned from my mentors, so here goes. As a reminder to all of the traders out there to leave your emotions at the door and never, ever, try to catch a falling safe. Simply let it crash to the ground and then, walk over and pick up the money. That is a reference to bounce plays LOL.

I strive to find breakout stock alerts and deliver them before the market finds out. I’m the original OG trend setter of trending stocks! If you want stocks delivered to your inbox, no hassle, no research with this massive community of traders, sign up below.

I sure hope you enjoyed this article, if you would like to receive more exclusive content from me sign up for our newsletter below 👇


[thrive_leads id=’14274′]

read more

QSI the good stock to buy? Important new development! URGENT Update

Mar 3, 2022

Quantum-Si Inc. QSI is a good stock to buy? Trending stock? Breakout stock? Is QSI the best stock to buy stock because it has been breaking it’s trend with large volume and a 26% change in PPS in 5 days. Wondering why this stock is taking off, take a look below. Before we do, remember to stop what you are doing and 👇 sign up for our newsletter below. 👇


[thrive_leads id=’14274′]

Before we get started, I wanted to introduce myself to you. Hi 🙋‍♂️ I’m Alexander Goldman and I have been successfully trading breakout stocks and trending stocks for two decades now.

I’m now helping traders find breakout stocks. My claim to fame is the expert at finding trending stocks.

What do I mean by big winners?

Stocks that move more than 100% in a month! QSI Stock Price could?

Does that always happen, NO! But, I’m very good! Take a look at this article I wrote, where I called 5 stocks, 3 losers and 2 winners and they all did what I thought!

The article is HERE where I shine a spotlight on trending stocks and breakout stocks!

Now, let’s go over if QSI is the best stock to buy? Below, is some of the basic information on this stock before we get in the technical analysis

Quantum-Si Inc. Company Information

Company Name: Quantum-Si Inc.

Ticker: QSI

Exchange: NASDAQ

Website: https://www.quantum-si.com/

Quantum-Si Summary:

Quantum-Si, Inc. develops a protein sequencing platform of proteomics. It offers single molecule analysis, and democratizing its use by providing researchers and clinicians access to the proteome. The company was founded by Jonathan M. Rothberg on June 24, 2013 and is headquartered in Guilford, CT. QSI the best stock to buy? Trending stock? Breakout stock?

QSI the best stock to buy? Let’s look at the News

Feb. 28, 2022—Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing single molecule protein sequencing, today announced financial results for the fourth quarter and fiscal year ended December 31, 2021.

  • Announced the appointment of Dr. Jonathan Rothberg, Founder and Executive Chairman of the Board, as Interim Chief Executive Officer.
  • Formed a new Scientific Advisory Board whose goal will be to identify high-impact, routine applications for single molecule protein sequencing across research, clinical, and diagnostics.
  • Established list prices for our protein sequencing platform in anticipation of commercial launch in 2022.
  • Shared a technical manuscript on bioRxiv providing an overview of Time Domain SequencingTM enabling massively-parallel single molecule protein sequencing at individual amino acid resolution on a semiconductor chip.
  • Entered into a lease agreement for new headquarters in New Haven, CT, close to Yale University.
  • Ended 2021 with $471.3 million in cash and cash equivalents and marketable securities and no debt, providing a sufficient runway to make key investments in the business.

QSI 5 Day Chart

QSI

Quantum-Si, Inc. QSI is not a good play right now, even though I like the company. It just went bearish!

I hope I did a good job with my analysis of QSI and if it is the best stock to buy?

This is Alex, reminding all the traders out there to leave your emotions at the door and never, ever, try to catch a falling knife. I strive to find breakout stock alerts and deliver them before the market finds out. I sure hope you enjoyed this article, if you would like to receive more exclusive content from me 👇 sign up for our newsletter below. 👇


[thrive_leads id=’14274′]

read more

Is TRVI is a good stock? It depends, is it a trending stock or a breakout stock?

Mar 2, 2022

Is TRVI a good stock to buy because it has been breaking it’s trend with large volume and a 153% change in PPS in 5 days. I will not make you wait to long to give my synopsis on two of the three questions. Is it a trending stock, YES! Is it a breakout stock, YES! The final question will be answered soon.

Wondering why this stock is taking off, take a look below. Before we do, remember to stop what you are doing and 👇 sign up for our newsletter below. 👇


[thrive_leads id=’14274′]

Before we get started, I wanted to introduce myself to you. Hi 🙋‍♂️ I’m Alexander Goldman and I have been successfully trading breakout stocks and trending stocks for two decades now.

What do I mean by big winners?

Stocks that move more than 100% in a month! TRVI Stock Price could?

Does that always happen, NO! But, I’m very good! Take a look at this article I wrote, where I called 5 plays, 3 losers and 2 winners and they all did what I thought!

The article is HERE where I shine a spotlight on trending stocks and breakout stocks!

Now, let’s go over if TRVI is a good stock to buy? Below, is some of the basic information before we get in the technical analysis

Trevi Therapeutics Company Information

Company Name: Trevi Therapeutics Inc.

Ticker: TRVI

Exchange: NASDAQ

Website: https://www.trevitherapeutics.com/

Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization Haduvio to treat serious neurologically mediated conditions. It includes treatment of chronic pruritus associated with prurigo nodularis and chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson’s disease. The company was founded by Thomas R. Sciascia and Jennifer L. Good in March 2011 and is headquartered in New Haven, CT.

Breakout stock TRVI News could be the reason that it is a good stock to buy, let’s review it’s latest press release to see.

Feb. 24, 2022

Announced positive interim analysis results of the Phase 2 Cough And NALbuphine (CANAL) trial of its investigational therapy Haduvio™ (nalbuphine ER) in idiopathic pulmonary fibrosis patients (IPF) suffering from chronic cough, establishing proof of concept. Further patient recruitment in the trial will stop based on the strength and consistency of the data.

TRVI 5 Day Chart

I already gave my synopsis earlier on two of the three questions.

Is it a trending stock, YES!

Is it a breakout stock, YES!

Yes it is, after it pulls back and consolidates. It’s trending bearish in the one day because of the volume spike and let the flippers get out, retrace a little, consolidate and breakouts with a double confirmation. Then have at it, it looks very good to me.

This is Alex, reminding all the traders out there to leave your emotions at the door and never, ever, try to catch a falling knife. I strive to find breakout alerts and deliver them before the market finds out. I sure hope you enjoyed this article, if you would like to receive more exclusive content from me 👇 sign up for our newsletter below. 👇


[thrive_leads id=’14274′]

read more

ANPC the best stock to buy? Trending stock? Breakout stock?

Mar 2, 2022

ANPC the best stock to buy? Trending stock? Breakout stock? Is ANPC the best stock to buy stock because it has been breaking it’s trend with large volume and a 26% change in PPS in 5 days. Wondering why this stock is taking off, take a look below. Before we do, remember to stop what you are doing and 👇 sign up for our newsletter below. 👇


[thrive_leads id=’14274′]

Before we get started, I wanted to introduce myself to you. Hi 🙋‍♂️ I’m Alexander Goldman and I have been successfully trading breakout stocks and trending stocks for two decades now.

I’m now helping traders find breakout stocks. My claim to fame is the expert at finding trending stocks.

What do I mean by big winners?

Stocks that move more than 100% in a month! ANPC Stock Price could?

Does that always happen, NO! But, I’m very good! Take a look at this article I wrote, where I called 5 stocks, 3 losers and 2 winners and they all did what I thought!

The article is HERE where I shine a spotlight on trending stocks and breakout stocks!

Now, let’s go over if AXAS is the best stock to buy? Below, is some of the basic information on this stock before we get in the technical analysis

Abraxas Petroleum Company Information

Company Name: Abraxas PAnPac Bio-Medical Science Co.

Ticker: ANPC

Exchange: NASDAQ

Website: https://www.anpacbio.com/

AnPac Bio-Medical Science Co. Summary:

Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. ANPC the best stock to buy? Trending stock? Breakout stock?

ANPC the best stock to buy? Let’s look at the News

Feb 03, 2022

Filed for a breakthrough device designation request for its cancer differentiation analysis (“CDA”) technology-based medical device; the company filed the request with the Food and Drug Administration (“FDA”) earlier this week. According to the announcement, the company’s novel CDA technology and medical device detects and analyzes biophysical signals in a blood sample to determine the risk level of more than 20 different types of cancers.AnPac Bio has collected more than 43,000 samples as the company has worked with hospitals and medical institutions in extensive retrospective and prospective clinical trials.

ANPC 5 Day Chart

best stock to buy

Great news was delivered with the Patent. The stock is down 88% on the 1 year coupled with the great news, I like it.

In the short term it could retrace a little more, so I would set my stop loss at $.75.

I hope I did a good job with my analysis of ANPC and if it is the best stock to buy?

This is Alex, reminding all the traders out there to leave your emotions at the door and never, ever, try to catch a falling knife. I strive to find breakout stock alerts and deliver them before the market finds out. I sure hope you enjoyed this article, if you would like to receive more exclusive content from me 👇 sign up for our newsletter below. 👇


[thrive_leads id=’14274′]

read more

Y-Mabs Theraputics YMAB Stock report, never seen insights by famed stock picker Alexander Goldman  

Feb 13, 2022

Y-mAbs Therapeutics YMAB stock has been breaking it’s trend with large volume and a 27% change in PPS in 1 day. Wondering why this stock is taking off, take a look. Before we do, remember to stop what you are doing and 👇 sign up for our newsletter below. 👇


[thrive_leads id=’14274′]

Before we get started, I wanted to introduce myself to you. Hi 🙋‍♂️ I’m Alexander Goldman and I have been successfully trading stocks for two decades now. I’m now helping traders find big movers now.

What do I mean by big winners?

Stocks that move more than 100% in a month!

Does that always happen, NO! But, I’m very good! Take a look at this article I wrote, where I called 5 stocks, 3 loswers and 2 winners and they all did what I thought!

The article is HERE

Now, let’s go over some of the basic information on this stock before we get in the technical analysis.

Y-mAbs Therapeutics Inc. Company Information

Company Name: Y-mAbs Therapeutics Inc.

Ticker: YMAB

Exchange: NASDAQ

Website: https://ymabs.com/

Y-mAbs Inc. Company Summary:

Y-mAbs is a commercial-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products. Used for the treatment of cancer. We have a broad and advanced product pipeline, including pivotal-stage product candidates against a range of targets.

Our mission is to become the world leader in developing better and safer antibody-based oncology products. Also, addressing clear unmet pediatric and adult medical needs. With the right partnerships and collaborations, we envision changing the course of cancer care and its outcomes.

YMAB News

Feb. 11, 2022

Announced that it recently completed a Pre-Biologics License Application (“pre-BLA”) meeting with the U.S. Food and Drug Administration (“FDA”) regarding a potential pathway for FDA approval of omburtamab for the treatment of patients with CNS/leptomeningeal metastases from neuroblastoma. The Company expects to resubmit the BLA for omburtamab by the end of the first quarter 2022.

YMAB 5 Day Chart

YMAB Stock

Y-mAbs Technical Analysis:

The news was great on YMAB ticker and I believe this stock could continue to run. $7.62 is where I put my stop loss, it looks like it should have a great Friday!

This is Alex, reminding all the traders out there to leave your emotions at the door and never, ever, try to catch a falling knife. I sure hope you enjoyed this article, if you would like to receive more exclusive content from me 👇 sign up for our newsletter below. 👇


[thrive_leads id=’14274′]

read more

Exicure XCUR has been on fire lately, up almost 50% in 5 days.

Feb 1, 2022

Exicure XCUR has been on fire lately, up almost 50% in 5 days after a massive amount of volume being injected into this little well known stock. The stock has been crashing for the last 6 months. I have written a full report on XCUR that you can read below.

However, before you read this insightful information, sign up below, let’s stay in contact.

XCUR

Exicure XCUR has some very bad press, check it out “UPCOMING DEADLINE ALERT: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm” Before we get started, let’s review some basic information on this company.

Exicure XCUR Company Summary

Company Name:  LimitExicure

Ticker: XCUR

Exchange: NASDAQ

Exicure, Inc. Company Summary

Exicure, Inc. is a development-stage biotechnology company developing therapeutics for neurology and rare genetic disorders based on its proprietary spherical nucleic acid (SNA™) technology. Exicure’s proprietary SNA architecture is designed to unlock the potential of therapeutic oligonucleotides in a wide range of cells and tissues. Exicure’s lead programs address neuroscience diseases and genetic disorders. Exicure is based in Chicago, IL.

SNA constructs overcome one of the most difficult obstacles to nucleic acid therapeutics: safe and effective delivery into cells and tissues. SNA constructs exhibit unparalleled transfection efficiency into numerous cell and tissue types, including the skin, without carriers or transfection agents.

SNA™ technology originated in the lab of Professor Chad A. Mirkin at the Northwestern University International Institute for Nanotechnology.

XCUR News

NEW YORK, NY / ACCESSWIRE / December 16, 2021 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Exicure, Inc. (“Exicure” or the “Company”) (NASDAQ:XCUR) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Exicure securities between March 11, 2021 and November 15, 2021, inclusive (the “Class Period”).

XCUR 1 Month Chart

XCUR

XCUR Technical Analysis

Why stocks go up baffles me, but this one has broken two resistance points and looks strong and BULLISH. I think its worth putting on your watchlist.

Remember, to never try and catch a falling safe, or a knife for that matter. Simply let it fall to the ground, walk over, and pick up the money and walk away. If you enjoyed this article, sign up below, I promise I will never spam you and I’m pretty darn good at picking winners. Let’s make some trades together!

XCUR

read more

Inspira Technologies IINN is Up, Why is That? Take a Look at This!

Jan 31, 2022

Inspira Technologies IINN is up 31% after due to a massive amount of volume being injected into this tech darling. I have written a full report on IINN that you can read below.

However, before you read this insightful information, sign up below, let’s stay in contact.

IINN

Inspira Technologies announced today, “it has signed an exclusive summary distribution agreement with Glo-Med Networks Inc. (“Glo-Med”), for distribution across 6 states in the United States (Texas, New Jersey, New York, Florida, North Carlina and South Carolina)” However, before we get started, let’s review some basic information on this company.

Limitless Venture Group LVGI Company Summary

Company Name:  Inspira Technologies Oxy B.H.N. Ltd.

Ticker: IINN

Exchange: NASDAQ

Website: www.inspirao2.com

Limitless Venture Group, Inc. Company Summary

Inspira Technologies is an innovative medical device company in the respiratory care industry. Inspira is developing the ART system, a cost effective early extracorporeal respiratory support system with an intent to function as an “Artificial Lung” for deteriorating respiratory patients.

The ART system is designed to utilize a hemo-protective flow approach aimed to rebalance saturation levels while patients are awake and breathing, potentially minimizing the patient’s need for mechanical ventilation. The Company’s product has not yet been tested or used in humans and has not been approved by the U.S. Food and Drug Administration (FDA) or the CE or other required regulatory agencies.

LVGI News

Jan. 31, 2022 

Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the “Company” or “Inspira Technologies”), a groundbreaking respiratory support technology company, announced today that it has signed an exclusive summary distribution agreement with Glo-Med Networks Inc. (“Glo-Med”), for distribution across 6 states in the United States (Texas, New Jersey, New York, Florida, North Carlina and South Carolina).

Jan. 28, 2022

Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW) (the “Company” or “Inspira Technologies”), a groundbreaking respiratory support technology company, announced today that has listed a component of its ART and ECLS systems on the U.S. Food and Drug Administration Class I 510(k) exempt list.

IINN 3 Month Chart

IINN

IINN Technical Analysis

The news was incredible that Inspira Technologies IINN released today was huge and the stock responded with a massive amount of volume and a PPS increase of almost 50%. IINN skyrocketed from $2.32 to $3.23.

The real question is, what is it going to do now? Well, it has pulled back as expected but it will now consolidate then make a move up or down depending on the indicators within the consolidation. It is too early to determine which way it will move, but it is showing an early tendency to bearish. Also, this stock sure loves going up and down!

Remember, to never try and catch a falling safe, or a knife for that matter. Simply let it fall to the ground, walk over, and pick up the money and walk away. If you enjoyed this article, sign up below, I promise I will never spam you and I’m pretty darn good at picking winners. Let’s make some trades together!

Inspira Technologies IINN

read more